Intercept Pharmaceuticals
ICPT
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)
Categories
P/S ratio for Intercept Pharmaceuticals (ICPT)
P/S ratio as of April 2024 (TTM): 2.50
According to Intercept Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.50152. At the end of 2023 the company had a P/S ratio of 2.44.
P/S ratio history for Intercept Pharmaceuticals from 2012 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.44 | 50.09% |
| 2022 | 1.63 | 22.76% |
| 2021 | 1.32 | -49.19% |
| 2020 | 2.61 | -83.87% |
| 2019 | 16.2 | -2.94% |
| 2018 | 16.6 | 48.64% |
| 2017 | 11.2 | -89.63% |
| 2016 | 108 | -91.75% |
| 2015 | > 1000 | -31.78% |
| 2014 | > 1000 | 135.06% |
| 2013 | 816 | 252.85% |
| 2012 | 231 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | 20.5 | 718.02% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.00 | 19.94% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.03 | -18.69% | 🇺🇸 USA |
 MediciNova MNOV | 65.0 | 2,498.85% | 🇺🇸 USA |